Bio-Rad Laboratories Other Long-Term Assets 2010-2024 | BIO
Bio-Rad Laboratories other long-term assets from 2010 to 2024. Other long-term assets can be defined as field containing the sum of all non-current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
- Bio-Rad Laboratories other long-term assets for the quarter ending September 30, 2024 were $0.098B, a 1.87% decline year-over-year.
- Bio-Rad Laboratories other long-term assets for 2023 were $0.095B, a 0.27% increase from 2022.
- Bio-Rad Laboratories other long-term assets for 2022 were $0.095B, a 9.2% decline from 2021.
- Bio-Rad Laboratories other long-term assets for 2021 were $0.104B, a 20.14% increase from 2020.
| Bio-Rad Laboratories Annual Other Long-Term Assets (Millions of US $) |
|
|---|---|
| 2023 | $95 |
| 2022 | $95 |
| 2021 | $104 |
| 2020 | $87 |
| 2019 | $80 |
| 2018 | $70 |
| 2017 | $95 |
| 2016 | $48 |
| 2015 | $65 |
| 2014 | $52 |
| 2013 | $55 |
| 2012 | $40 |
| 2011 | $210 |
| 2010 | $173 |
| 2009 | $125 |
| Bio-Rad Laboratories Quarterly Other Long-Term Assets (Millions of US $) |
|
|---|---|
| 2024-06-30 | $98 |
| 2024-03-31 | $93 |
| 2023-12-31 | $95 |
| 2023-09-30 | $98 |
| 2023-06-30 | $100 |
| 2023-03-31 | $96 |
| 2022-12-31 | $95 |
| 2022-09-30 | $102 |
| 2022-06-30 | $101 |
| 2022-03-31 | $104 |
| 2021-12-31 | $104 |
| 2021-09-30 | $107 |
| 2021-06-30 | $99 |
| 2021-03-31 | $92 |
| 2020-12-31 | $87 |
| 2020-09-30 | $82 |
| 2020-06-30 | $80 |
| 2020-03-31 | $78 |
| 2019-12-31 | $80 |
| 2019-09-30 | $73 |
| 2019-06-30 | $64 |
| 2019-03-31 | $65 |
| 2018-12-31 | $70 |
| 2018-09-30 | $73 |
| 2018-06-30 | $75 |
| 2018-03-31 | $78 |
| 2017-12-31 | $95 |
| 2017-09-30 | $58 |
| 2017-06-30 | $58 |
| 2017-03-31 | $53 |
| 2016-12-31 | $48 |
| 2016-09-30 | $64 |
| 2016-06-30 | $65 |
| 2016-03-31 | $66 |
| 2015-12-31 | $65 |
| 2015-09-30 | $46 |
| 2015-06-30 | $50 |
| 2015-03-31 | $49 |
| 2014-12-31 | $52 |
| 2014-09-30 | $50 |
| 2014-06-30 | $49 |
| 2014-03-31 | $46 |
| 2013-12-31 | $55 |
| 2013-09-30 | $36 |
| 2013-06-30 | $382 |
| 2013-03-31 | $380 |
| 2012-12-31 | $40 |
| 2012-09-30 | $301 |
| 2012-06-30 | $270 |
| 2012-03-31 | $263 |
| 2011-12-31 | $210 |
| 2011-09-30 | $202 |
| 2011-06-30 | $212 |
| 2011-03-31 | $206 |
| 2010-12-31 | $173 |
| 2010-09-30 | $151 |
| 2010-06-30 | $136 |
| 2010-03-31 | $142 |
| 2009-12-31 | $125 |
| 2009-09-30 | $125 |
| 2009-06-30 | $112 |
| 2009-03-31 | $92 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $10.282B | $2.671B |
| Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and biological materials and discovery, analysis and purification of their components. Bio-Rad has extensive and direct distribution channels outside the United States through subsidiaries which focus on sales, customer service and product distribution. The company operates through two reportable segments - Life Science segment which designs, manufactures, markets and services reagents, apparatus and instruments utilized for biological research. Clinical Diagnostics - This business markets and distributes products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians office laboratories, transfusion laboratories as well as insurance and forensic testing laboratories. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $204.059B | 26.03 |
| Stryker (SYK) | United States | $139.868B | 31.52 |
| Boston Scientific (BSX) | United States | $124.863B | 35.90 |
| Medtronic (MDT) | Ireland | $114.537B | 17.04 |
| EssilorLuxottica (ESLOY) | France | $110.799B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $45.365B | 0.00 |
| Haleon (HLN) | United Kingdom | $44.180B | 28.71 |
| GE HealthCare Technologies (GEHC) | United States | $39.743B | 20.61 |
| ResMed (RMD) | United States | $35.761B | 29.39 |
| Terumo (TRUMY) | Japan | $28.532B | 40.29 |
| Koninklijke Philips (PHG) | Netherlands | $25.454B | 19.48 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.582B | 13.74 |
| Baxter (BAX) | United States | $18.264B | 12.39 |
| Insulet (PODD) | United States | $16.648B | 70.04 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.052B | 0.00 |
| BellRing Brands (BRBR) | United States | $8.726B | 36.90 |
| Demant (WILYY) | Denmark | $8.351B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $8.016B | 19.24 |
| ICU Medical (ICUI) | United States | $4.201B | 40.09 |
| TG Therapeutics (TGTX) | United States | $3.771B | 0.00 |
| Haemonetics (HAE) | United States | $3.763B | 18.61 |
| Envista Holdings (NVST) | United States | $3.662B | 27.28 |
| Prestige Consumer Healthcare (PBH) | United States | $3.657B | 18.22 |
| Perrigo (PRGO) | Ireland | $3.466B | 10.95 |
| Neogen (NEOG) | United States | $3.127B | 36.08 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.988B | 18.00 |
| QuidelOrtho (QDEL) | United States | $2.628B | 16.56 |
| Agios Pharmaceuticals (AGIO) | United States | $2.557B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $2.260B | 38.14 |
| LeMaitre Vascular (LMAT) | United States | $2.165B | 52.65 |
| Curaleaf Holdings (CURLF) | Canada | $2.023B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.960B | 0.00 |
| Warby Parker (WRBY) | United States | $1.769B | 0.00 |
| AtriCure (ATRC) | United States | $1.641B | 0.00 |
| InMode (INMD) | Israel | $1.460B | 8.78 |
| AdaptHealth (AHCO) | United States | $1.365B | 9.85 |
| Verano Holdings (VRNOF) | United States | $1.231B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.179B | 0.00 |
| Evolus (EOLS) | United States | $1.036B | 0.00 |
| Owens & Minor (OMI) | United States | $0.925B | 7.23 |
| National Vision Holdings (EYE) | United States | $0.915B | 29.08 |
| Phibro Animal Health (PAHC) | United States | $0.906B | 18.80 |
| CeriBell (CBLL) | United States | $0.893B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.844B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.747B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.542B | 16.36 |
| Surmodics (SRDX) | United States | $0.536B | 113.85 |
| Quanterix (QTRX) | United States | $0.532B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.515B | 0.00 |
| Valneva SE (VALN) | France | $0.475B | 0.00 |
| ZimVie (ZIMV) | United States | $0.398B | 33.56 |
| Viemed Healthcare (VMD) | United States | $0.331B | 35.54 |
| Aurora Cannabis (ACB) | Canada | $0.328B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.315B | 8.12 |
| TerrAscend (TSNDF) | Canada | $0.309B | 0.00 |
| Jin Medical (ZJYL) | China | $0.308B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.293B | 0.00 |
| Cerus (CERS) | United States | $0.290B | 0.00 |
| Biote (BTMD) | United States | $0.280B | 12.93 |
| Ayr Wellness (AYRWF) | United States | $0.279B | 0.00 |
| Zynex (ZYXI) | United States | $0.255B | 53.33 |
| Omeros (OMER) | United States | $0.246B | 0.00 |
| High Tide (HITI) | Canada | $0.234B | 97.00 |
| MacroGenics (MGNX) | United States | $0.232B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.225B | 15.14 |
| Organigram Holdings (OGI) | Canada | $0.195B | 0.00 |
| Brainsway (BWAY) | Israel | $0.172B | 206.40 |
| FitLife Brands (FTLF) | United States | $0.145B | 19.54 |
| Rockwell Medical (RMTI) | United States | $0.121B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.117B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.113B | 0.00 |
| Veru (VERU) | United States | $0.107B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.097B | 23.90 |
| Fonar (FONR) | United States | $0.092B | 9.51 |
| Jushi Holdings (JUSHF) | United States | $0.092B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.082B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.079B | 0.00 |
| InterCure (INCR) | Israel | $0.079B | 0.00 |
| Modular Medical (MODD) | United States | $0.073B | 0.00 |
| Safety Shot (SHOT) | United States | $0.065B | 0.00 |
| Sanuwave Health (SNWVD) | United States | $0.064B | 1.63 |
| MariMed (MRMD) | United States | $0.062B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.047B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.045B | 0.00 |
| Exagen (XGN) | United States | $0.043B | 0.00 |
| Apyx Medical (APYX) | United States | $0.040B | 0.00 |
| ImmuCell (ICCC) | United States | $0.028B | 0.00 |
| Flora Growth (FLGC) | United States | $0.020B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.015B | 0.00 |
| Nephros (NEPH) | United States | $0.015B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.013B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.006B | 0.00 |
| Agape ATP (ATPC) | $0.006B | 0.00 | |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Senestech (SNES) | United States | $0.001B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 17.87 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |